Product Description
1. Technical Specifications
| Attribute |
Details |
| Brand Name |
Azadine Injection |
| Generic Name |
Azacitidine |
| Strength |
Commonly available in 100 mg per vial |
| Dosage Form |
Lyophilized powder for injection (reconstituted before use) |
| Packaging Size |
Single-use vial |
| Packaging Type |
Glass vial with sterile packaging |
| Medicine Type |
Anticancer / Hypomethylating agent |
| Manufacturer |
Varies by country (e.g., Intas, Cadila, Dr. Reddys, others in India) |
| Distributed By |
Licensed oncology distributors / specialty pharmacies |
2. Product Description
Azadine Injection contains Azacitidine, a nucleoside metabolic inhibitor and DNA methyltransferase inhibitor.
It works by incorporating into RNA and DNA, thereby causing hypomethylation of DNA and direct cytotoxicity on abnormal hematopoietic cells.
This restores normal function of some genes and reduces proliferation of malignant cells.
3. Product Highlights
| Attribute |
Details |
| Therapeutic Category |
Anticancer (Hypomethylating Agent) |
| Application Area |
Myelodysplastic syndromes (MDS), Acute Myeloid Leukemia (AML), Chronic Myelomonocytic Leukemia (CMML) |
| Mechanism of Action |
Inhibits DNA methyltransferase DNA hypomethylation reactivates tumor suppressor genes + direct cytotoxic effects |
| Administration |
Subcutaneous (SC) or Intravenous (IV) injection |
| Storage Conditions |
Store below 25C, protect from light; reconstituted solution must be used within specified time (usually 45 minutes for IV, up to 8 hours refrigerated for SC) |
4. Therapeutic Uses
-
Myelodysplastic Syndromes (MDS): including all French-American-British (FAB) subtypes.
-
Acute Myeloid Leukemia (AML): newly diagnosed AML in older adults or those unsuitable for intensive chemotherapy.
-
Chronic Myelomonocytic Leukemia (CMML).
5. Side Effects
Common:
-
Nausea, vomiting, diarrhea, constipation
-
Injection site reactions (pain, redness, rash)
-
Fatigue, weakness
-
Fever, infections (due to low blood counts)
-
Anemia, neutropenia, thrombocytopenia
-
Headache, dizziness
Serious / Severe:
-
Severe bone marrow suppression high infection/bleeding risk
-
Hepatotoxicity (rare, more in patients with liver disease)
-
Renal toxicity (rare but possible)
-
Tumor lysis syndrome (rare, in high tumor burden cases)
6. Precautions
-
Blood Monitoring: CBC before each cycle to manage cytopenias.
-
Liver & Kidney Monitoring: Periodic LFTs and renal function tests required.
-
Infection Risk: Treat infections promptly; avoid exposure to contagious illness.
-
Pregnancy & Breastfeeding: Contraindicated; teratogenic potential.
-
Handling Precautions: Cytotoxicmust be handled with care by healthcare professionals.
-
Elderly Patients: More prone to hematologic toxicitiesdose adjustment may be needed.
Reliable Pharmaceutical Distribution Across IndiaAzadine Injection is distributed, exported, and supplied by reputable companies across India, ensuring stringent quality standards and timely delivery. Whether you are a wholesaler, trader, or healthcare provider, you can trust the consistent availability and regulated supply chain of the product. Our structured distribution network guarantees that authentic Azadine Injection reaches medical professionals without compromise on safety or efficacy.
Guaranteed Quality and Professional UseThis injectable medication is manufactured and offered in strict compliance with pharmaceutical guidelines. Azadine Injection is provided in liquid form and recommended exclusively for adult patients, ensuring targeted treatment under professional supervision. The controlled administration enhances patient safety and optimizes the therapeutic outcome.
FAQs of Azadine Injection:
Q: How should Azadine Injection be stored for maximum effectiveness?
A: Azadine Injection should be stored in a cool and dry place to maintain its stability and effectiveness. Avoid exposing the injection to heat, moisture, or direct sunlight, as these conditions may compromise its quality.
Q: What is the proper way to administer Azadine Injection?
A: This medication should only be administered as an injection by a qualified doctor or healthcare professional, and the dosage must follow the specific instructions provided by the prescribing physician.
Q: When should Azadine Injection be used during treatment?
A: Azadine Injection is used as part of a treatment regimen prescribed by a doctor, typically according to a specific schedule. Timing and frequency are determined by the healthcare provider based on each patients individual medical needs.
Q: Where can I procure Azadine Injection in India?
A: Azadine Injection is available through authorized distributors, exporters, suppliers, traders, and wholesalers throughout India. Purchase only from verified and reputable sources to ensure product authenticity and quality.
Q: What is the process for distributing Azadine Injection in India?
A: Distribution involves regulated channels, including exporters, suppliers, traders, and wholesalers who adhere to strict pharmaceutical standards. Delivery is managed to ensure the medication remains safe and effective until it reaches healthcare professionals.
Q: What are the main benefits of using Azadine Injection under medical supervision?
A: When used as directed by a doctor, Azadine Injection can deliver targeted, effective treatment while minimizing risks. Professional administration helps maximize therapeutic outcomes and promotes patient safety.
Q: Who is Azadine Injection suitable for and what precautions should be taken?
A: Azadine Injection is suitable for adults only and must be used solely under the guidance of a qualified doctor. Always follow storage instructions and never self-administer this injection without proper medical supervision.